ABBV Chief Executive

What Robert A. Michael says in public, and what their own SEC filings show they own.

Robert A. Michael

Chairman of the Board & CEO · AbbVie Inc.

Became CEO in 2024, added Chairman role effective July 2025; previously President & COO, CFO; 30+ years at Abbott/AbbVie.

Leadership & board →

What they own

Ownership

Skin in the game

Level 1Steward

Michael owns about 0% of AbbVie Inc., worth $47.4M at the last close.

SEC filings: 23

Stake 178,737 reported shares ≈ 0.0% of shares outstanding — no 13G on file, so an estimate 4/35

Founder Not assessed — whether they founded the company has not been researched Not assessed

Tenure No start date on record, so tenure scores nothing 0/10

Track record Not assessed — their prior companies have not been researched Not assessed

Direction No open-market buys or sales in the last year 5/15

Discipline No late Form 4s in 23 filings 10/10

Nobody has researched this person's career yet, so founder and track record are left out of the score and of the total above.

Score = stake band (35) + founder (15) + tenure (10) + track record (15) + 12-month direction (−10…15) + filing discipline (10). An axis we have not researched is left out of the score and of the total it is shown over. Every input links to a filing or to our own research; the bands are ours.

Reported · Forms 3, 4, 5 178,737 Every lot on the person's own filings, as of Feb 27, 2026

Paper trail On time No Form 4 filed outside the two-day window; form 144 flagged below

Reported AbbVie Inc. shares Forms 3, 4 and 5 · as of 2026-02-27

Dots mark the months the activity below moved the line. Hover one for that month's net move, how many movements it folds and the largest.

How the stake is held

Security	Held via	Shares
Common Stock, $0.01 par value	Direct	178,737
Reported as of 2026-02-27		178,737

Held directly: 100%
Vehicles: None
Last filing: Mar 3, 2026

Activity · last 12 months 2 events folded from 5 filing lines · Every filing on EDGAR ↗

Date	Type	What happened	Shares	Price	Value	Note
Feb 27, 2026 filing: Tax, Shares withheld for tax · Common Stock, $0.01 par value	Tax	Shares withheld for tax · Common Stock, $0.01 par value	−36,523	$232.08	$8.5M
Feb 18, 2026 filing: Award, Grant or award across 4 lots · Common Stock, $0.01 par value	Award	Grant or award across 4 lots · Common Stock, $0.01 par value	+82,439	—	—

Every issuer Robert A. Michael files as an insider of

Company	Role	Reported	Beneficial	% of class
ABBV AbbVie Inc. This page	CHAIRMAN OF THE BOARD AND CEO	178,737 2026-02-27	—	—

Reported is every lot on the person's own Forms 3, 4 and 5 — direct and through trusts. Beneficial is the figure stated on the latest Schedule 13D/G cover page, which can exclude shares the person disclaims and include options exercisable within 60 days, so the two are never added together.